The scientific journal ‘Cells’ publishes a new study developed by Grupo Park with the collaboration of Fundación Isabel Gemio

The scientific journal ‘Cells’, with almost 7.7 impact factor, has published the results of a study on autophagy modifications in myotonic dystrophy type I, developed by Group Park researchers with the collaboration of Fundación Isabel Gemio.

Grupo Park has been studying the molecular mechanisms involved in the aetiology of neurodegenerative diseases for 20 years. It is part of the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) of the Instituto de Salud Carlos III (ISCIII) and the Instituto Universitario de Investigación Biosanitaria de Extremadura (INUBE).

The research centre assures us that they continue to work on the same line of myotonic dystrophy type I and hope to be able to offer more tangible results soon.

Read the study in the following link: CELLS

PRESS: SIGLO XXI / Infosalus